{
    "Trade/Device Name(s)": [
        "QuickVue Influenza A + B test"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K053146",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031899",
        "K991633"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "December 14, 2005",
    "Summary Letter Received Date": "November 10, 2005",
    "Submission Date": "November 9, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A antigen",
        "Influenza B antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal wash",
        "Nasal aspirate"
    ],
    "Specimen Container(s)": [
        "Extraction tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Test strip"
    ],
    "Method(s)/Technology(ies)": [
        "Lateral-flow immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Reagent",
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for QuickVue Influenza A + B lateral-flow immunoassay for detection of influenza A and B antigens.",
    "Indications for Use Summary": "Aids in rapid differential diagnosis of acute influenza type A and type B viral infections from nasal or nasopharyngeal specimens; not intended for influenza C antigen detection; negative results should be confirmed by cell culture; for professional and laboratory use.",
    "fda_folder": "Microbiology"
}